# MitrAssist

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mitrassist-2

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Total disclosed funding: $170M
- Latest round: Series C (Sep 1, 2023)
- Investors on record: 9

## About

Established in 2017 and based in Shanghai, China, MitrAssist is a medical device company that focuses on the research and development of cardiovascular medical devices. In September 2023, the frim raised approximately USD 100 million in series C funding co-led by returning investors 6 Dimensions Capital and Centurium Capital. Other new investors Anyuan Fund, Binhu Science City, Hefei Haiheng Capital Management Co., Ltd., Hefei State-Owned Assets Holding, and Jiading Venture Capital also participated in the round. On September 22, 2023, MitrAssist signed a CNY 2 billion R&D industrialization project for cardiovascular products and high-value consumables with Hefei City.

The company's main products include interventional heart valve (mitral valve, tricuspid valve and aortic valve) treatment products, interventional coronary drug balloon products, and interventional heart failure treatment products.

The company will use the series C funding for the clinical development of mitral valve replacement products and aortic polymer valve products.

## Funding rounds

- Series C, Sep 1, 2023, $100M — 6 Dimensions Capital, Jiading Venture Capital, Centurium Cap, Hefei State-Owned Assets Holding, Anyuan Fund, Hefei Haiheng Capital Management Co., Ltd., Binhu Science City
- Series B, Dec 30, 2020, $70M — China International Capital Corporation, CITIC Securities, 6 Dimensions Capital, Centurium Cap

## Investors

- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series B
- CITIC Securities — Series B
- 6 Dimensions Capital (https://capitalatlas.ai/funds/6-dimensions-capital) — Series B, Series C
- Centurium Cap — Series B, Series C
- Jiading Venture Capital (https://capitalatlas.ai/funds/jiading-venture-capital) — Series C
- Hefei State-Owned Assets Holding (https://capitalatlas.ai/funds/hefei-state-owned-assets-holding) — Series C
- Anyuan Fund (https://capitalatlas.ai/funds/anyuan-fund) — Series C
- Hefei Haiheng Capital Management Co., Ltd. — Series C
- Binhu Science City — Series C